NAV
10.12(0.50%)Fund Size (CR)
₹335.88Expense Ratio
0.72Scheme Type
Active FundValue Research
Min. investment
₹500Minimum Additional Investment
₹100Minimum SIP Investment
₹500Minimum Withdrawal
₹500Exit Load
1%Return Since Launch
1.16%
- 3M
- 6M
- 1Y
- 3Y
- All
Basic Details
Scheme Manager
Nimesh Chandan
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 7 November 2025 | 10161.73 | 1.62% | - | 1.01% | 141/936 |
| 1 Month | 14 October 2025 | 10188.34 | 1.88% | - | 2.01% | 495/924 |
| 3 Month | 14 August 2025 | 10255.47 | 2.55% | - | 4.59% | 722/912 |
| 6 Month | 14 May 2025 | 10882.10 | 8.82% | - | 7.83% | 254/868 |
| 1 Year | - | - | - | - | - | -/- |
| 3 Year | - | - | - | - | - | -/- |
| 5 Year | - | - | - | - | - | -/- |
| Since Inception | 27 December 2024 | 10116.00 | 1.16% | 1.16% | 13.70% | 841/934 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 1 January 2025 | 1,10,000 | 116829.95 | 6.21% | 6.21% |
| 3 Year | - | - | - | - | - |
| 5 Year | - | - | - | - | - |
| 10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
- Investment type
- Scheme based
- SIP
- Lumpsum
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
5.13%
Standard Deviation
1.13%
Beta
-0.64%
Sharpe Ratio
-0.05%
Treynor's Ratio
-9.62%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Divi's Lab. | 8.81% | 43936 | 29.60 | Equity | Pharmaceuticals |
| Sun Pharma.Inds. | 7.66% | 152234 | 25.74 | Equity | Pharmaceuticals |
| Apollo Hospitals | 6.26% | 27355 | 21.01 | Equity | Healthcare |
| Cipla | 5.00% | 111911 | 16.80 | Equity | Pharmaceuticals |
| Neuland Labs. | 4.09% | 8339 | 13.74 | Equity | Pharmaceuticals |
| Biocon | 3.76% | 339568 | 12.64 | Equity | Pharmaceuticals |
| Fortis Health. | 3.66% | 120183 | 12.30 | Equity | Healthcare |
| Piramal Pharma | 3.24% | 545316 | 10.89 | Equity | Pharmaceuticals |
| Emcure Pharma | 3.22% | 82002 | 10.82 | Equity | Pharmaceuticals |
| Aurobindo Pharma | 3.18% | 93695 | 10.67 | Equity | Pharmaceuticals |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| Bajaj Finserv Healthcare Fund - Direct (IDCW) | 335.88 | 1.88% | 2.55% | 8.82% | - | - | |
| Nippon India Taiwan Equity Fund - Direct (G) | 421.51 | 4.21% | 14.03% | 46.24% | 44.70% | 37.87% | |
| Nippon India Taiwan Equity Fund - Direct (IDCW) | 421.51 | 4.21% | 14.03% | 46.24% | 44.70% | 37.87% | |
| Aditya Birla SL International Equity Fund - Direct (G) | 273.51 | -0.77% | 2.77% | 16.62% | 28.48% | 16.30% | |
| Aditya Birla SL International Equity Fund - Direct (IDCW) | 273.51 | -0.77% | 2.77% | 16.62% | 28.48% | 16.30% | |
| Quant BFSI Fund - Direct (G) | 680.73 | 4.78% | 9.14% | 20.47% | 26.41% | - |
List of Schemes under Bajaj Finserv Mutual Fund
News
Bajaj Finserv Mutual Fund announces change in Key Personnel
Bajaj Finserv Mutual Fund has announced the Ms. Lakshmi Iyer have been appointed as an (Associate, non-executive, non-independent and additional Director) on the board of Bajaj Finserv Mutual Fund Trustee Limited, with effect from November 04, 2025.Details of Ms. Lakshmi Iyer
Age: 48 years
Designation: (Associate, non-executive, non-independent and additional Director)
Qualification: B. Com from R.A Podar College, Diploma in Business Management, Narsee Monjee Institute of Management Studies (NMIMS)
Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
6 December 2024
Total AUM (Cr)
₹335.88
Bajaj Finserv Healthcare Fund - Direct (IDCW) is an Sectoral / Thematic-oriented fund from the renowned AMC, Bajaj Finserv Mutual Fund. Launched in 6 December 2024, this fund is managed by Nimesh Chandan. With assets under management (AUM) worth ₹335.88 (Cr), as of 14 November 2025, Bajaj Finserv Healthcare Fund - Direct (IDCW) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 1.16% since its launch.
The current NAV of Bajaj Finserv Healthcare Fund - Direct (IDCW) is ₹10.12, as on 14 November 2025. The fund's benchmark index is BSE Healthcare TRI. You can invest in Bajaj Finserv Healthcare Fund - Direct (IDCW) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹500 while the minimum lumpsum investment is ₹500.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
If units are redeemed / switched out within 3 months from the date of allotment: 1% of applicable NAV. If units are redeemed/switched out after 3 months from the date of allotment, no exit load is payable. The fund has generated undefined% and undefined% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 92.33% in Equity, 4.38% in Debt and 3.29% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 61.89% in Pharmaceuticals & Biotech, 20.51% in Healthcare Services, 3.19% in Personal Products, 2.35% in Cash & Others, 2.17% in Food Products